Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population

Vaccine

Volumn 24, Issue 12, 2006, Pages 2043-2048

  Knuf, Markus ^a   Zepp, Fred ^a   Meyer, Claudius ^a   Grzegowski, Edith ^b   Wolter, Joanne ^b   Riffelmann, Marion ^c   Wirsing Von König, Carl Heinz ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

Adolescents; Pertussis; Tdap vaccine

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; TETANUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; GERMANY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERTUSSIS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; VACCINATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; MALE; WHOOPING COUGH;

EID: 32844469466     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.024     Document Type: Article

References (17)

1. K.M. Edwards Pertussis vaccine S.A. Plotkin W.A. Orenstein Vaccines 4th ed. 2004 WB Saunders Philadelphia, PA 471 528
2. A.M. Wendelboe, A. van Rie, S. Salmaso, and J.A. Englund Duration of immunity against pertussis after natural infection or vaccination Ped Inf Dis J 24 2005 S59 S61
3. K.D. Forsyth, M. Campins-Marti, J. Caro, J.D. Cherry, D. Greenberg, and N. Guiso Global Pertussis Initiative. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative Clin Infect Dis 39 2004 1802 1809
4. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut Version January 2000: Epidem Bull 2000;2:9-20
5. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut Version July 2002: Epidem Bull 2002;28:227-42
6. C.H. Wirsing von Koenig, and H.J. Schmitt Epidemiological aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine J Infect Dis 174 1996 S281 S286
7. W.K. Yih, S.M. Lett, F.N. des Vignes, K.M. Garrison, P.L. Sipe, and K.D. Marchant The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998 J Infect Dis 182 2000 1409 1416
8. J.L. Deen, C.A. Mink, J.D. Cherry, P.D. Christenson, E.F. Pineda, and K. Lewis Household contact study of Bordetella pertussis infections Clin Infect Dis 21 1995 1211 1219
9. C.H. Wirsing von König, D. Gounis, H.J. Schmitt, S. Laukamp, and H. Bogaerts Single sample serological diagnosis of pertussis Eur J Clin Microbiol Infect Dis 18 1999 341 345
10. J. Storsaeter, H.O. Hallander, L. Gustafson, and P. Olin Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis Vaccine 20 1998 1907 1916
11. N.N. Tran Mnh, Q. He, A. Ramalho, A. Kaufhold, M.K. Viljanen, and H. Arvilommi Acellular Vaccines containing reduced quantities of pertussis antigens as a booster in adolescents Pediatrics 104 1999 1377 1378
12. M. Van der Wielen, P. Van Damme, E. Joossens, G. Francois, F. Meurice, and A. Ramalho A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults Vaccine 18 2000 2075 2082
13. P. Van Damme, and M. Burgess Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults Vaccine 22 2004 305 308
14. K.J. Edelman, Q. He, J.P. Makinen, M.S. Haanpera, N.N. Tran Minh, and L. Schuerman Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine Clin Infect Dis 39 2004 179 185
15. T. Le, J.D. Cherry, S.J. Chang, M.D. Knoll, M.L. Lee, and S. Barenkamp APERT Study: immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study J Infect Dis 190 2004 535 544
16. K.M. Edwards, B.D. Meade, M.D. Decker, G.F. Reed, M.B. Rennels, and M.C. Steinhoff Comparison of 13 acellular pertussis vaccines: overview and serologic response Pediatrics 96 1995 548 557
17. H.J. Schmitt, C.H. Wirsing von König, A. Neiss, H. Bogaerts, H.L. Bock, and H. Schulte-Wissermann Efficacy of a three-component acellular pertussis vaccine (DTap) after a primary course in infants as evaluated after household exposure to pertussis JAMA 275 1996 37 41